Tumour histology and primary site but not MDM2 amplification levels are prognostic for clinical outcomes in well differentiated and dedifferentiated liposarcoma

被引：0
|
作者：
Chew, W. H. W. [1 ]
Chan, J. Y. [1 ]
Goh, W. L. [1 ]
Lim, J. H. C. [2 ]
Tan, S. H. [2 ]
Somasundaram, N. [1 ]
Poon, E. Y. L. [1 ]
Lim, A. S. T. [3 ]
Tan, M. H. [4 ]
Soo, K. C. [5 ]
Teo, M. [5 ]
Tay, T. K. Y. [6 ]
Selvarajan, S. [6 ]
Sittampalam, K. [6 ]
Quek, R. [1 ]
机构：
[1] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[2] Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Sci, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Mol Pathol, Singapore, Singapore
[4] Singapore Gen Hosp, Dept Orthopaed Surg, Singapore, Singapore
[5] Natl Canc Ctr Singapore, Div Surg Oncol, Singapore, Singapore
[6] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
487O
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [41] MDM2 Amplification in Atypical Lipomatous Tumors/Well-Differentiated Liposarcomas and Dedifferentiated Liposarcomas: A Comparative RT-PCR and FISH Study
    Willems, J. G.
    Gjihaderi, M.
    Olsson, A.
    Lestrin, M.
    Elmberger, G.
    MODERN PATHOLOGY, 2010, 23 : 393A - 393A
  • [42] Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin
    Fabbroni, Chiara
    Fuca, Giovanni
    Ligorio, Francesca
    Fumagalli, Elena
    Barisella, Marta
    Collini, Paola
    Morosi, Carlo
    Gronchi, Alessandro
    Dei Tos, Angelo Paolo
    Casali, Paolo Giovanni
    Sanfilippo, Roberta
    CANCERS, 2021, 13 (06) : 1 - 10
  • [43] High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases
    Ricciotti, Robert W.
    Baraff, Aaron J.
    Jour, George
    Kyriss, McKenna
    Wu, Yu
    Liu, Yuhua
    Li, Shao-Chun
    Hoch, Benjamin
    Liu, Yajuan J.
    CANCER GENETICS, 2017, 218 : 69 - 80
  • [44] Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma
    Weaver, Joshua
    Goldblum, John R.
    Turner, Sondra
    Tubbs, Raymond R.
    Wang, Wei-Lein
    Lazar, Alexander J. F.
    Rubin, Brian P.
    MODERN PATHOLOGY, 2009, 22 (01) : 66 - 70
  • [45] Amplification of FRS2 in Atypical Lipomatous Tumor/Well -Differentiated Liposarcoma and Dedifferentiated Liposarcoma Clinicopathological and Genetic Study of 146 Cases
    Jing, Wenyi
    Lan, Ting
    Chen, Huijiao
    Zhang, Zhang
    Chen, Min
    Peng, Ran
    He, Xin
    Zhang, Hongying
    LABORATORY INVESTIGATION, 2018, 98 : 25 - 25
  • [46] Amplification of FRS2 in Atypical Lipomatous Tumor/Well -Differentiated Liposarcoma and Dedifferentiated Liposarcoma Clinicopathological and Genetic Study of 146 Cases
    Jing, Wenyi
    Lan, Ting
    Chen, Huijiao
    Zhang, Zhang
    Chen, Min
    Peng, Ran
    He, Xin
    Zhang, Hongying
    MODERN PATHOLOGY, 2018, 31 : 25 - 25
  • [47] Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma:: Special emphasis on the distinct immunophenotype of the well-differentiated component
    Adachi, T
    Oda, Y
    Sakamoto, A
    Saito, T
    Tamiya, S
    Masuda, I
    Tsuneyoshi, M
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2001, 9 (02) : 99 - 109
  • [48] Well-Differentiated Laryngeal/Hypopharyngeal Liposarcoma in the MDM2 Era Report of Three Cases and Literature Review
    Zhu H.
    Sun J.
    Wei S.
    Wang D.
    Brandwein M.
    Head and Neck Pathology, 2017, 11 (2) : 146 - 151
  • [49] Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
    Ray-Coquard, Isabelle
    Blay, Jean-Yves
    Italiano, Antoine
    Le Cesne, Axel
    Penel, Nicolas
    Zhi, Jianguo
    Heil, Florian
    Rueger, Ruediger
    Graves, Bradford
    Ding, Meichun
    Geho, David
    Middleton, Steven A.
    Vassilev, Lyubomir T.
    Nichols, Gwen L.
    Binh Nguyen Bui
    LANCET ONCOLOGY, 2012, 13 (11): : 1133 - 1140
  • [50] MDM4 amplification in a case of de-differentiated liposarcoma and in-silico data supporting an oncogenic event alternative to MDM2 amplification in a subset of cases
    Pissaloux, Daniel
    Le Loarer, Francois
    Decouvelaere, Anne-Valerie
    Paindavoine, Sandrine
    Houlier, Aurelie
    Vernay, Lionel
    Bland, Vincent
    Coindre, Jean-Michel
    Blay, Jean-Yves
    Ranchere-Vince, Dominique
    HISTOPATHOLOGY, 2017, 71 (06) : 1019 - 1023
12345